Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The AI claims provided in the input are consistent with the supplied prescribing information for the fixed-dose combination product’s indication (seasonal allergic rhinitis in adults and pediatric patients 6 years and older) and with the label’s mechanism statements that the product includes an H1-receptor antagonist (azelastine) plus a synthetic corticosteroid (fluticasone). No contradictions are present in the claims given.
Category Scores
Accurate Statements
Azelastine is an antihistamine (an H1-receptor antagonist).
Label 11 DESCRIPTION states the product contains an antihistamine (H1 receptor antagonist) as an active ingredient.
Azelastine’s primary and established pharmacologic action is antihistamine activity, not anticholinergic activity.
Label 12.1 Mechanism of Action describes azelastine hydrochloride as an H1-receptor antagonist; no anticholinergic mechanism is described for azelastine in the provided label excerpt.
Azelastine is used for allergic symptoms such as allergic rhinitis.
Label 1 INDICATIONS AND USAGE indicates the combination product is for relief of symptoms of seasonal allergic rhinitis.
The product is indicated for relief of symptoms of seasonal allergic rhinitis in adult and pediatric patients 6 years of age and older.
Label 1 INDICATIONS AND USAGE.
Azelastine works by blocking histamine receptors (H1 antagonism).
Label 12.1 Mechanism of Action: azelastine hydrochloride exhibits histamine H1-receptor antagonist activity.
Azelastine does not block muscarinic acetylcholine receptors.
No muscarinic acetylcholine receptor blocking is described in the provided label excerpt; however, the excerpt does not explicitly state this negative claim.
Some medications can have anticholinergic-like side effects due to different receptor targets, formulation, or off-target effects.
Not addressed in the provided label excerpt.
Unsupported Statements
Azelastine is used for allergic symptoms such as allergic conjunctivitis.
The supplied label excerpt only specifies seasonal allergic rhinitis; it does not mention allergic conjunctivitis.
Azelastine reduces allergy-related symptoms like sneezing.
The supplied label excerpt does not list specific rhinitis symptom examples (e.g., sneezing).
Azelastine reduces allergy-related symptoms like itching.
The supplied label excerpt does not list specific rhinitis symptom examples (e.g., itching).
Azelastine reduces allergy-related symptoms like runny nose.
The supplied label excerpt does not list specific rhinitis symptom examples (e.g., runny nose).
Azelastine does not block muscarinic acetylcholine receptors.
The provided label excerpt supports H1-receptor antagonist activity but does not explicitly state that muscarinic receptors are not blocked.
Some medications can have anticholinergic-like side effects due to different receptor targets, formulation, or off-target effects.
Not supported or addressed in the provided label excerpt.
Contradictions
Important Omissions
Dosage and administration details for the product were not evaluated because the provided AI claims did not include dosing. If dosing was intended, it is omitted from the provided AI content.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
Unsupported statements were related to symptom examples and conjunctivitis use, which are not supported by the provided label excerpt. No claims in the provided AI content directly contradicted the provided prescribing information.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Several symptom-specific and conjunctivitis-related uses are not supported by the supplied label excerpt (which only specifies seasonal allergic rhinitis). Also, the negative muscarinic-receptor claim is not explicitly supported in the excerpt.
Suggested Improvement
Limit symptom and indication descriptions to what the label excerpt supports (seasonal allergic rhinitis). Avoid unverified negative receptor claims (e.g., muscarinic blocking) unless the label explicitly states them.